perindopril has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanorskaia, IuS; Kanorskiĭ, SG | 1 |
| Kinugawa, S | 1 |
1 review(s) available for perindopril and Diabetic Neuropathies
| Article | Year |
|---|---|
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
1 other study(ies) available for perindopril and Diabetic Neuropathies
| Article | Year |
|---|---|
[Atrial fibrillation in patients with type 2 diabetes mellitus: specific features of development and antirecurrence therapy].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atrial Fibrillation; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Neuropathies; Drug Monitoring; Female; Heart Conduction System; Heart Failure, Diastolic; Humans; Male; Middle Aged; Perindopril; Random Allocation; Secondary Prevention; Sotalol; Thioctic Acid; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |